Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain practical insight into how integrating MOUD prescribing into pharmacy practice can improve treatment access while maintaining safe, evidence-based care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Korey Kreider, PharmD
Pharmacist Owner
Medicine Man

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent federal policy changes authorizing pharmacists to independently prescribe buprenorphine for opioid use disorder.
2. Identify clinical, regulatory, and workflow considerations associated with integrating MOUD prescribing into pharmacy practice

Rachel Maynard and Korey Kreider have no relevant financial relationships with ineligible companies to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-150-H01-P
Initial release date: 5/11/2026
Expiration date: 5/11/2027
Additional CPE details can be found here.